To study diclofenac sodium induced histological and mechanical alterations and their prevention with Imipenem in rat intestine. METHODS: Male Wistar rats (n=240) were randomly assigned to four experimental groups: GI: n=60 treated with 0.9% saline IM; GII: n=60 treated with 6mg/kg body weight diclofenac sodium IM for four days; GIII: n=60 treated with 30mg/kg body weight Imipenem IM for four days, and GIV n=60 treated with diclofenac sodium plus Imipenem at the above doses IM for 4 days. Each group was further divided into 4 subgroups of 15 rats each and sacrificed at 4, 7, 14, and 21 days of follow-up, respectively. Abdominal cavity macroscopy and histology, and small bowel breaking strength were analyzed at each sacrifice moment. RESULTS: There were no histological or mechanical alterations in normal control rats throughout the study. Ulcerated lesions in intestinal mucosa were observed and breaking strength decreased in all diclofenac sodium treated rats. Ulcerated lesions in intestinal mucosa were prevented by Imipenem in all rats. CONCLUSION: Diclofenac sodium induced ulcerated lesions in rat intestinal mucosa can be prevented by Imipenem treatment. Key words: Diclofenac. Imipenem. Intestine, Small. Ulcer. Rats.
Introduction
Detailed study of the inflammatory process has permitted the development of a medication group generically referred to as non-steroid anti-inflammatory drugs (NSAIDs), which have the specific function of blocking the inflammatory process cascade and consequently reduce pain intensity 1 . Diclofenac sodium (DS)
is one NSAID that acts on the arachidonic acid cascade inhibiting prostaglandin biosynthesis, and is one of most commonly used drugs in experimental and clinical investigations 2 .
Patients who make long-term use of NSAIDs can develop inflammatory processes, stenosis, and ulcers (non-or perforated)
in the small intestine or colon 3 . However, the mechanism(s) responsible for these alterations is still not fully understood 4 .
NSAIDs are used after surgery as preventive (before surgical incision) or therapeutic (after anaesthesia effect)
analgesics and anti-inflammatories aiming to block the liberation of substances that change the excitation threshold in peripheral nocireceptors and alleviate moderate or mild intensity pain 5 .
However, these drugs also have undesirable side effects, such as intestinal anastomosis rupture. Clinical and experimental findings have also shown that NSAIDs can provoke ulcers in intestinal mucosa in locations without anastomosis, which can evolve to perforation 6 . Although the exact etiopathogenicity of these intestinal mucosa lesions is not fully known, NSAIDs probably facilitate intercellular junction breaks thus favouring bacteria translocation 7 .
The line of research followed by our group is to find explanations for probable modulating factors which affect intestinal healing, using non-anastomosis rats to simulate the adverse conditions found in clinical practice. This type of investigation attempts to find new ways of avoiding possible NSAID complications 2 .
Due to the increasing use of DS after surgery and in an effort to obtain more information on how DS acts on intestinal mucosa lesions and their prevention, the aim of our study was to evaluate small intestine lesions induced by DS, their evolution and biomechanical alterations -rupture force of the small intestine distal portion, and to verify whether antibiotics (Imipenem) prevent their formation.
Methods
Two month old male Wistar rats (n=240) with 190g mean weight were randomly distributed into four groups, as follows:
Group I: n=60, received one daily application of 05mL 0.9% SF In all groups, treatments were applied over 4 consecutive days. Figure 1 shows the experimental design At each time point (4, 7, 14 and 21 days), 15 rats underwent macroscopic study of the abdominal cavity and terminal ileum, rupture force, and histological examination of ileum fragments, which were 10cm distant from the ileocaecal valve.
From each animal, a 3cm and 2cm segment were removed from the ileum terminal and immediately placed in PBS with 250mg/mL papaverine chloride at 37°C for 30min. In sequence, rupture force of these segments was measured. Distal ileum fragments (0.5cm) were used for histopathology. These fragments were opened from the contramesenterial side, with the mucosa face extended on filter paper and immersed in 10% formalin solution.
Following this procedure, samples from the large omentum, large and small intestine, liver anterior lobe, and spleen were taken. Factorial analysis of variance for completely random experiments was used to evaluate the following hypotheses:
1)
Interaction between antibiotic and antiinflammatory on each evaluation day;
2) Anti-inflammatory effect;
3) Antibiotic effect;
4)
The time effect in each of the four groups.
The following statistics were calculated in each hypothesis tested: F and p (p=probability of erroneous conclusion by significance). Effects were considered significant when p<0.05.
In these cases differences between pairs of means were made by calculating the minimum significant difference for α=0.05, by Tukey's method.
Results
No deaths occurred in any group. Only GII animals presented reduced food ingestion, diarrhoea, and weight loss up There was also granulation tissue, newly formed vessels and a large reduction in edema in relation to that seen in adherences from the fifth day. On Days 14 and 21 no lesions were found in animal intestine mucosa. Figure 4 shows data from the rupture force study. There is statistical difference between groups A1B1 and A1B2. There is interaction between the use of anti-inflammatory and antibiotic (p<0.001), as shown in groups A2B1 and A2B2. These results suggest that DS was responsible for the formation of ulcerated lesions in intestinal mucosa.
The fact that some of these lesions compromised the serosa layer showed that they can evolve to perforation and consequently peritonitis; this probably did not occur as DS was suspended on day 4. Despite ulcerated lesions being seen in intestinal mucosa, they were not found in gastric mucosa; we were unable to explain the mechanism behind this, which is also unexplained in the literature 10 . One theory is enterohepatic circulation, which can more easily appear with some anti-inflammatories from the NSAID group 11 .
Preferential distribution of lesions on the mesenterial side of the intestinal wall could suggest that the positioning of blood and lymphatic vessels in this area has some importance in the genesis of these lesions. However, optical microscopic examination did not reveal alterations, which might explain its etiopathogenesis.
In contrast, ulcerated lesions in the intestinal mucosa did . This type of mechanism allows passage of antigens to the lymphatic system and important
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It is important to stress that the permeability and absorption mechanisms are different, as an increase in permeability does not necessarily imply higher absorption. This can be seen in celiac diseases where increased mucosa permeability coexists with situations of inadequate absorption.
The initial breach point of NSAID lesions in the mucosa barrier is still unknown due to the plurality of their action mechanism. Therefore, the initial lesion may correspond to just one physical-chemical change which provides an access for previously blocked ions by similarity in load polarity. The intercellular junction could potentially be the first to be affected due to its susceptibility to different nocive stimuli. There is also evidence that intercellular junctions are the first organelles to suffer when supplied with insufficient energy 14 .
In 1999, Verderese 14 showed, by electron microscopy that the intercellular junction in small intestine was opened in DS rats. However, no bacterias have been seen in that part, but they trespassing the intestinal barrier through the enterocyte.
Probably other mechanisms may lead this passage. On the other hand, contact from bacteria and consequently their toxins can damage or destroy the enterocyte in a process that can overtake the regenerative capacity of intestinal mucosa, leading to the formation of an ulcerated lesion.
Initial bacteria passage also seems to be related to a bacteria's ability to adhere to intestinal mucous One hypothesis is that the quantitative and qualitative stability of intestinal flora is responsible for the mucosa's resistance to colonisation by exogenous microorganisms. Also the bactericide or bacteriostasis activity of an antibiotic on a specific group of bacteria could be a paradoxical effect in bacteria passage.
In this way dynamic intestinal flora equilibrium is established by anaerobic bacteria and also by another group of bacteria 14 .
The 
Conclusions
Diclofenac sodium induced ulcerated lesions in rat intestinal mucosa can be prevented by Imipenem treatment. Diclofenac sodium, Imipenem, or both reduce intestine wall mechanical resistance.
